- Anniversary/History
- Membership
- Publications
- Resources
- Education
- Events
- Outreach
- Careers
- About
- For Pain Patients and Professionals
Papers: 6 Apr 2019 - 12 Apr 2019
Pharmacology/Drug Development
PAIN TYPE:
Migraine/Headache
2019 Apr 04
Curr Treat Options Neurol
21
4
The role of onabotulinumtoxinA in headache management was serendipitously found over a decade ago and approved for chronic migraine in 2010 based on pivotal studies. The purpose of this review is to highlight the impact on headache and other health parameters which is critically reviewed, as well as the putative mechanisms of action.